Karyopharm Therapeutics Inc —— 资产负债表 (NASDAQ:KPTI) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 313.05 M305.31 M358.17 M240.44 M164.42 M108.42 M 负债总额 262.5 M384.98 M374.83 M376.64 M350.44 M401.34 M 权益总额 50.55 M-79.67 M-16.66 M-136.21 M-186.02 M-292.93 M 负债及股东权益总额 313.05 M305.31 M358.17 M240.44 M164.42 M108.42 M 总债务 117.93 M169.29 M170.1 M170.92 M94.6 M115.81 M 净债务 -131.31 M-59.32 M-107.86 M-20.52 M-14.11 M52.1 M

新闻

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm: Putting The Phase 3 Trial In Context (NASDAQ:KPTI)

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slideshow (NASDAQ:KPTI) 2026-03-25

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript

Why Is Karyopharm Therapeutics Stock Trading Lower Today? - Karyopharm Therapeutics (NASDAQ:KPTI)

Rodman & Renshaw首次覆盖Karyopharm股票并给予买入评级

Rodman & Renshaw initiates Karyopharm stock with buy rating

Cantor Fitzgerald重申Karyopharm股票评级,看好试验前景

Cantor Fitzgerald reiterates Karyopharm stock rating on trial outlook

Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade